VIDEOS: BDP of Friday, March 20, 2026
The article presents a variety of news items including requests from Iran's new supreme leader, commentary on the impact of war on security perceptions in Dubai and Qatar, information on a legal case affecting elections, updates on diabetes medication in Brazil, tax declaration programs, and music festival news.
VIDEOS: Good Morning Rio on March 20, 2026
The article discusses various topics including the execution of a wrestler in Iran, issues with diabetes medication costs in Brazil, a recent transfer indicating cooperation in a corruption case, tax return preparation in Brazil, and highlights from the Lollapalooza festival.
Obesity medication linked to better mental health
A study reveals that semaglutide, an active ingredient in diabetes and obesity medication, is associated with reduced sickness absence and healthcare needs due to mental health issues in over 95,000 Swedes.
Anvisa approves multidose version of Mounjaro for type 2 diabetes and obesity
Brazil's Anvisa has approved a multidose version of the diabetes and obesity medication Mounjaro, allowing for multiple uses from a single vial.
Anvisa approves new version of Mounjaro with multiple doses in a single pen
Brazil's health regulatory agency, Anvisa, has approved a new multidose version of the diabetes medication Mounjaro, allowing patients to use a single pen for multiple doses.
Anvisa approves medication that can delay the onset of type 1 diabetes
Anvisa has approved teplizumab, a medication that can potentially postpone the onset of type 1 diabetes for patients aged 8 and older in Brazil.
Anvisa approves medication that may delay the onset of type 1 diabetes; understand what changes
The Brazilian health agency Anvisa has approved a new medication that may help delay the progression of type 1 diabetes in patients.
The FDA warns Novo Nordisk about failures in reporting side effects of Ozempic and Wegovy
The FDA has criticized Novo Nordisk for its inadequate reporting procedures regarding side effects of the diabetes medication Ozempic and the weight-loss drug Wegovy.
Is Tirzepatide the same as Mounjaro? Learn more about the medication
Tirzepatide is the active ingredient in Mounjaro, but they are not the same thing; Mounjaro is a brand name for the medication containing tirzepatide.
An embarrassing side effect was found in diabetes medication
A recent study has revealed a potential embarrassing side effect associated with the use of GLP-1 agonists for diabetes treatment, indicating a higher likelihood of developing chronic cough among type 2 diabetes patients compared to those on other diabetes medications.
"My weight skyrocketed": the most feared adverse effect of Ozempic that a Victoria's Secret model experienced
Remi Bader, a Victoria's Secret model, reported severe weight gain and adverse side effects associated with the diabetes medication Ozempic, which she used to manage her weight and health issues.
Should pharmaceutical companies advertise to consumers?
The article discusses the personal experience of Tamar Abrams, who turned to Ozempic, a diabetes medication associated with weight loss, due to health issues stemming from personal hardships and the influence of advertising.
Health Ministry maintains refusal and bars new drug to protect kidneys of diabetics in SUS
The Brazilian Health Ministry has decided not to incorporate finerenone, a drug for chronic kidney disease associated with type 2 diabetes, into the Unified Health System (SUS).
The patent for the most expensive diabetes drug has been revoked. Are cheaper alternatives closer to reimbursement?
A patent for dapagliflozin, a leading diabetes medication, has been revoked, potentially paving the way for cheaper generic versions to be reimbursed in Poland.
Common diabetes drug may help preserve eyesight as people age
Research indicates that the diabetes medication metformin can reduce the risk of age-related vision loss in older patients.
Common diabetes drug could prevent long Covid, scientists discover
A widely used diabetes medication, metformin, may prevent long Covid if taken early, potentially reducing the risk by 40% to 50%.
Nurse and husband arrested in the interior of SP with medication banned in Brazil
A nurse and her husband were arrested in Marília, Brazil, for possessing an illegal medication intended for obesity and diabetes control.
Novo sues American competitor for selling copy medicine
Novo Nordisk is suing an American competitor to stop the sale of copies of its weight loss and diabetes medications in the USA and to seek compensation for losses.
21.5 stone woman loses 10 stone in 6 months eating same meal every day
A 22-year-old woman from Manchester loses 10 stone in six months by following a strict diet and taking a weight loss medication called Mounjaro.
Shares in Ozempic manufacturer plummet
Shares of the manufacturer of Ozempic, a popular diabetes medication, have taken a significant downturn.
Diabetes drug metformin may treat 'ticking time bomb' that kills 4,000 a year
Researchers are exploring the potential of metformin, a diabetes medication, to treat a serious condition that leads to 4,000 deaths annually.
Ozempic for type 2 diabetes: Weight loss observed in many patients but not approved for all
The article discusses the use of Ozempic for type 2 diabetes, noting that while many patients experience weight loss, it is not approved for everyone.